In January 2019, Bristol-Myers Squibb and Celgene Corporation announced that they had entered into a definitive merger agreement for BMS to acquire Celgene for $74 billion. In this free webinar we discuss the proposed BMS acquisition of Celgene along with the forces behind and the potential divesture scenarios to see how the technology landscape will be affected;
the effect of M&As on the innovation landscape is becoming more important for policy makers; and lessons from decisions in the Dow/DuPont merger and how these might impact Bristol-Myers Squibb.
Join Gene Quinn, patent attorney and the President & CEO of IPWatchdog, Inc., on Thursday, February 14, 2019, at 12pm EST for a free webinar discussion Drafting Software Patents: Lessons from Key Lighthouse Cases. Joining Gene will be John White, patent expert, lecturer and partner with Berenato & White, and Megan McLoughlin, patent attorney with LexisNexis IP.
Our website uses cookies to provide you with a better experience. Read our privacy policy for more information.Accept and Close